东材科技、高盟新材、毅昌科技均表示，收到《四川省监察委员会立案通知书》《四川省监察委员会留置通知书》，熊海涛被四川省监察委员会立案调查并 实施留置，目前尚待四川省监察委员会进一步调查。对于被留置原因，高盟新材在公告中披露称，涉嫌犯罪。 资料显示，熊海涛1964年出生，旗下核心资产高金技术产业集团有限公司（以下简称"高金集团"）同时系前述三家上市公司控股股东。据天眼查股权全景穿 透图，截至最新，熊海涛持有99.7%高金集团股份。熊海涛直接及间接分别持有高盟新材、毅昌科技、东材科技28.35%、25.25%、22.86%的股份。 手握三家A股上市公司的61岁资本"大佬"熊海涛突遭留置、立案！1月27日晚间，东材科技（601208）、高盟新材（300200）、毅昌科技（002420）接连披 露公告称，实控人熊海涛被立案调查并实施留置。从熊海涛旗下三家上市公司的基本面来看，2025年前三季度均处于盈利状态，不过毅昌科技净利同比下 滑。 值得一提的是，在本次遭留置、立案前，熊海涛正筹划出让毅昌科技控制权。2025年12月25日晚间，毅昌科技披露公告称，公司控股股东将由高金集团变为 蔚然合伙，公司实际控制人将由熊海涛变更 ...

1月27日晚间，四川东材科技（601208）集团股份有限公司(以下简称"东材科技"或"公司")发布关于公司实际控制人、副董事长被留置的公告。 据该公告显示，公司实控人为熊海涛，直接持有公司股份1848.79万股，通过公司股东高金技术产业集团有限公司、高金富恒集团有限公司间接持有公司 股份2.15亿股。熊海涛出生于1964年，中山大学工商管理硕士，现任高金富恒集团有限公司执行董事、广州毅昌科技股份有限公司副董事长、四川东材科 技集团股份有限公司副董事长、北京高盟新材（300200）料股份有限公司副董事长，并直接或间接持股超千家关联企业。其2026年1月因个人原因不再担 任毅昌科技副董事长及非独立董事。 财报显示，东材科技成立于1994年，于2011年在上海证券交易所上市，总部位于四川省绵阳市，主要从事化工新材料的研发、制造和销售，以新型绝缘材 料为基础，重点发展光学膜材料、电子材料、环保阻燃材料等系列产品，可广泛应用于发电设备、特高压输变电、新能源汽车、轨道交通、消费电子、光 电显示、电工电器、通信网络、汽车装饰等领域。 业绩方面，2025年前三季度，东材科技实现营业收入38.03亿元，同比增长17.18%；实 ...

手握三家A股上市公司的61岁资本"大佬"熊海涛突遭留置、立案！1月27日晚间，东材科技（601208）、高盟新材（300200）、毅昌科技（002420）接连披 露公告称，实控人熊海涛被立案调查并实施留置。从熊海涛旗下三家上市公司的基本面来看，2025年前三季度均处于盈利状态，不过毅昌科技净利同比下 滑。 东材科技、高盟新材、毅昌科技均表示，收到《四川省监察委员会立案通知书》《四川省监察委员会留置通知书》，熊海涛被四川省监察委员会立案调查并 实施留置，目前尚待四川省监察委员会进一步调查。对于被留置原因，高盟新材在公告中披露称，涉嫌犯罪。 高盟新材主要业务分为复合粘接材料、交通功能材料、电气功能材料、低碳涂层材料、光学显示材料五大类，2025年前三季度实现归属净利润约为1.14亿 元，同比增长3.58%；东材科技则主要从事化工新材料的研发、制造和销售，当期实现归属净利润约为2.83亿元，同比增长19.8%。 二级市场方面，截至1月27日收盘，高盟新材、毅昌科技、东材科技总市值分别约为62.02亿元、35.99亿元、271.54亿元。经计算，熊海涛旗下三家A股上市 公司总市值合计近370亿元。 资料显示，熊海涛1 ...

Core Viewpoint - The Hong Kong IPO market is experiencing a surge in demand, with Guoen Technology Co., Ltd. (referred to as "Guoen") launching its H-share offering, indicating strong investor interest and confidence in the company's growth potential [1][4]. Group 1: IPO Details - Guoen's H-share offering consists of 30 million shares, with approximately 10% allocated for public sale in Hong Kong and 90% for international investors [1]. - The price range for the H-share issuance is set between HKD 34 and HKD 42, with the public offering portion exceeding HKD 3.3 billion and an oversubscription rate of nearly 30 times [1][4]. Group 2: Investor Confidence - The cornerstone investor lineup for Guoen's IPO includes prominent institutions such as Liguan Investment, SLD International, and Luminous Horizon, collectively planning to subscribe for approximately HKD 320 million of the offering [4][5]. - The backing from these institutional investors reflects a strong market perception of Guoen's long-term value and growth prospects [5]. Group 3: Company Strengths - Guoen is recognized as the second-largest producer of organic polymer modified materials and organic polymer composite materials in China, and the largest producer of polystyrene by capacity [7]. - The company serves major clients in the home appliance, automotive, and new energy sectors, including Hisense, Midea, BYD, and CATL [7]. - In the health sector, Guoen controls Dongbao Biological, covering the entire industrial chain from gelatin raw materials to hollow capsules, ranking second in bone gelatin production and second among domestic brands in hollow capsule production in China [7]. Group 4: Fund Utilization - Guoen plans to allocate approximately 50% of the raised funds to establish a new production base in Thailand to expand capacity, while 35% will be used to enhance the production capacity of its Yixing facility [9]. - This strategic expansion aligns with the trend of downstream industries, such as home appliances and automotive, moving overseas, thereby opening new growth opportunities for the company [9].

IPO 申购指南 国恩科技（2768.HK） 建议申购 2026-1-27 星期二 | 【招股详情】 | | | | --- | --- | --- | | 保荐人 | 招商证券国际 | | | 上市日期 | 年 2026 | 月 日（星期三） 2 4 | | 招股价格 | 34~42 | 港元/股（中间价：38 港元/股） | | 集资额 | 10.577 | 亿港元（扣除包销费及佣金，按中间价计算） | | 每手股数 | 200 股 | | | 入场费 | 8,484.71 | 港元 | | 招股日期 | 2026 年 | 1 月 27 日-2026 年 1 月 30 日 | | 国元证券认购截止日期 | 2026 年 | 1 月 29 日 | | 招股总数 | 3,000 | 万股(可予调整及视乎超额配售权的行使情况而定) | | 国际配售 | 2,700 | 万股(可予调整及视乎超额配售权的行使情况而定)，约占 90% | | 公开发售 | 300 | 万股(可予调整及视乎超额配售权的行使情况而定)，约占 10% | 【申购建议】 公司是一家专注于化工新材料及明胶、胶原蛋白上下游产品的中国供货商。 公 ...

Investment Rating - The report recommends subscription for the company, Guo'en Technology, with an IPO price range of HKD 34 to HKD 42 per share, suggesting a valuation of approximately 15 times the net profit for 2024 [3]. Core Insights - Guo'en Technology is a Chinese supplier focused on chemical new materials and gelatin, serving both the chemical and health industries. It ranks as the second-largest organic polymer modified materials and composite materials company in China by sales revenue, with a market share of 2.5% [2]. - The global polymer materials market is projected to grow from RMB 29.89 trillion in 2020 to RMB 45.61 trillion by 2024, with a compound annual growth rate (CAGR) of 11.1%. The Chinese polymer materials market is expected to expand from RMB 11.08 trillion in 2020 to RMB 16.28 trillion by 2024, with a CAGR of 10.1% [2]. - The company's revenue for 2022, 2023, and 2024 is forecasted to be RMB 13.41 billion, RMB 17.44 billion, and RMB 19.19 billion, respectively, reflecting a CAGR of 19.6%. Net profits for the same years are projected at RMB 663.11 million, RMB 465.89 million, and RMB 676.38 million [3]. Summary by Relevant Sections IPO Details - The IPO is set to raise HKD 10.577 billion, with a total offering of 30 million shares, of which 27 million shares are allocated for international placement and 3 million shares for public offering [1]. Market Position - Guo'en Technology is the second-largest producer of bone gelatin and the second-largest domestic brand producer of hollow capsules in China, indicating a strong market presence [2]. Financial Performance - The company is currently in a stable growth phase, with a significant safety margin in its valuation based on the IPO pricing compared to its A-share closing price [3].

每经头条（nbdtoutiao）——国际金价冲破5000美元！7年涨了280%，什么时候才见顶？专家：关键还 看美元，重点关注国际货币体系、降息和科技革命 （记者 曾健辉） 每经AI快讯，晶华新材1月27日晚间发布公告称，上海晶华胶粘新材料股份有限公司实际控制人、控股 股东周晓东先生截至目前持有公司股份约3941万股，占公司总股本的13.57%。本次部分股份解除质押 后，周晓东先生累计质押公司股份245万股，占其持有公司股份总数的6.22%，占公司总股本的0.84%。 公司控股股东及实际控制人周晓南先生、周晓东先生，及其一致行动人周锦涵先生合计持有公司股份约 9478万股，合计占公司总股本32.64%。 ...

Core Viewpoint - Guoen Technology (02768.HK) plans to globally offer 30 million H-shares, with 3 million shares available in Hong Kong and 27 million shares for international distribution, aiming for a price range of HKD 34.00 to 42.00 per share, with trading expected to commence on February 4, 2026 [2][3] Company Overview - Guoen Technology specializes in chemical new materials and gelatin, collagen, and related products, serving both the chemical and health industries [3] - The company operates in two main sectors: the large chemical sector, providing solutions to manufacturers in automotive, new energy, and home appliances, and the health sector, supplying raw materials for supplements and pharmaceuticals [3][4] Market Position - In the large chemical industry, Guoen is the second-largest company in China for organic polymer modified materials and organic polymer composite materials, holding a market share of 2.5% as of 2024 [4] - Guoen is also the largest producer of polystyrene in China by production capacity as of 2024 [4] Financial Performance - The company has shown strong revenue growth, with revenues of RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion for the fiscal years 2022, 2023, and 2024 respectively, reflecting a compound annual growth rate (CAGR) of 19.6% from 2022 to 2024 [7] - The sales figures for the fiscal years 2023 and 2024 indicate year-on-year growth rates of 30.1% and 10.0%, respectively [7] Market Trends - The market for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion by 2024, with a CAGR of 15.7% [8] - The market is expected to continue strong growth, reaching RMB 1,037.5 billion by 2029, with a forecasted CAGR of 14.1% from 2025 to 2029 [8] Use of Proceeds - The net proceeds from the share offering are estimated at approximately HKD 1.057 billion, with plans to allocate 50% for establishing a new production base in Thailand, 35% for expanding capacity in Yixing, and 10% for investments in Hong Kong [9]

Group 1 - The core viewpoint of the news is that Guoen Technology (国恩科技) is preparing for its IPO in the Hong Kong market, with a strong foundation and significant fundraising expectations [2][4] - Guoen Technology plans to globally issue approximately 30 million H-shares, with 3 million shares allocated for public offering in Hong Kong and 27 million shares for international offering [2] - The expected net fundraising amount is approximately HKD 1.058 billion, with funds allocated for expanding production capacity in Thailand and China, as well as for operational purposes [2][4] Group 2 - Guoen Technology specializes in new chemical materials and collagen products, serving the chemical and health industries, focusing on R&D, production, and sales [4] - The company ranks second in the organic polymer modification and composite materials industry in China by sales revenue, with a market share of 2.5%, and is the largest producer of polystyrene in China [4] - In the health sector, Guoen Technology's subsidiary, Dongbao Biological, has established a complete layout from collagen raw materials to end products, becoming a comprehensive group in the health segment [4] Group 3 - For the fiscal years 2022 to 2024, Guoen Technology's revenues were RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion, with corresponding profits of RMB 0.724 billion, RMB 0.540 billion, and RMB 0.721 billion [5] - The company has shown solid performance in its financial results, indicating a stable growth trajectory [5]

1月27日，鲁西化工跌5.04%，截至发稿，报18.67元/股，成交4.08亿元，换手率1.13%，总市值355.54亿 元。 资料显示，鲁西化工集团股份有限公司位于山东聊城高新技术产业开发区化工新材料产业园，成立日期 1998年6月11日，上市日期1998年8月7日，公司主营业务涉及化工新材料、基础化工及其他业务。主营 业务收入构成为：化工新材料产品66.07%，基础化工产品20.11%，化肥产品12.06%，其他产品1.76%。 从鲁西化工十大流通股东角度 数据显示，易方达基金旗下1只基金位居鲁西化工十大流通股东。易方达中证红利ETF（515180）三季 度增持57.67万股，持有股数804.68万股，占流通股的比例为0.42%。根据测算，今日浮亏损失约796.64 万元。 易方达中证红利ETF（515180）基金经理为林伟斌、宋钊贤。 截至发稿，林伟斌累计任职时间12年331天，现任基金资产总规模1194.08亿元，任职期间最佳基金回报 80.11%， 任职期间最差基金回报-22.14%。 宋钊贤累计任职时间5年146天，现任基金资产总规模598.17亿元，任职期间最佳基金回报68.14%， 任 职期间 ...